The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses

MN Hill, M Haney, CJ Hillard, DS Karhson… - Psychological …, 2023 - cambridge.org
Cannabis is well established to impact affective states, emotion and perceptual processing,
primarily through its interactions with the endocannabinoid system. While cannabis use is …

Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for cannabis-drug interactions

S Nasrin, CJW Watson, YX Perez-Paramo… - Drug Metabolism and …, 2021 - ASPET
The legalization of cannabis in many parts of the United States and other countries has led
to a need for a more comprehensive understanding of cannabis constituents and their …

Inhibition of UDP-glucuronosyltransferase enzymes by major cannabinoids and their metabolites

S Nasrin, CJW Watson, K Bardhi, G Fort, G Chen… - Drug Metabolism and …, 2021 - ASPET
The UDP-glucuronosyltransferase (UGT) family of enzymes play a central role in the
metabolism and detoxification of a wide range of endogenous and exogenous compounds …

Differential interactions of selected phytocannabinoids with human CYP2D6 polymorphisms

HC Huff, A Vasan, P Roy, A Kaul, E Tajkhorshid… - Biochemistry, 2021 - ACS Publications
Cytochrome P450 2D6 (CYP2D6) is primarily expressed in the liver and in the central
nervous system. It is known to be highly polymorphic in nature. It metabolizes several …

Characterizing and quantifying extrahepatic metabolism of (−)-Δ9-tetrahydrocannabinol (THC) and its psychoactive metabolite,(±)-11-hydroxy-Δ9-THC (11-OH-THC)

AR Kumar, GI Patilea-Vrana, O Anoshchenko… - Drug metabolism and …, 2022 - ASPET
(−)-Δ9-Tetrahydrocannabinol (THC) is the psychoactive constituent of cannabis, a drug
recreationally consumed orally or by inhalation. Physiologically based pharmacokinetic …

Development and Verification of a Linked Δ9-THC/11-OH-THC Physiologically Based Pharmacokinetic Model in Healthy, Nonpregnant Population and Extrapolation …

GI Patilea-Vrana, JD Unadkat - Drug Metabolism and Disposition, 2021 - ASPET
Conducting clinical trials to understand the exposure risk/benefit relationship of cannabis
use is not always feasible. Alternatively, physiologically based pharmacokinetic (PBPK) …

Estimation of fetal-to-maternal unbound steady-state plasma concentration ratio of P-glycoprotein and/or breast cancer resistance protein substrate drugs using a …

J Peng, MK Ladumor, JD Unadkat - Drug Metabolism and Disposition, 2022 - ASPET
Pregnant women are frequently prescribed drugs to treat chronic diseases such as human
immunodeficiency virus infection, but little is known about the benefits and risks of these …

Quantifying hepatic enzyme kinetics of (-)-∆ 9-Tetrahydrocannabinol (THC) and its psychoactive metabolite, 11-OH-THC, through in vitro modeling

GI Patilea-Vrana, JD Unadkat - Drug Metabolism and Disposition, 2019 - ASPET
The prevalence of cannabis use and the concentrations of the psychoactive cannabinoid in
cannabis,(-)-∆ 9-tetrahydrocannabinol (THC), are rising. Physiologically based …

Investigating Sex and Gender Influences on the Use and Effects of Cannabis

M Wright - 2023 - search.proquest.com
Sex and gender differences have been demonstrated in the use, harms, and effects of
cannabis and in cannabis use disorder. However, research investigating these differences is …

Characterizing the Neurological Bioactivity of Cannabis Phytochemicals

JS Laws - 2024 - digital.library.adelaide.edu.au
Amyloid β (Aβ) aggregation and its associated neurotoxicity are the leading pathological
hallmarks of Alzheimer's disease (AD), resulting in oxidative stress and neuronal death …